Brazil / Country's Largest Private Pharma Company Under Threat
Founded in 1950, EMS is one of the top two domestic pharma companies in Brazil. As a key player in the largest and…
Ferring Brazil
Last updated: 13.02.2014
Address: Praça São Marcos, 624 05455-050 – São Paulo – SP,Brazil
Tel: 0800-772-4656
Web: http://www.ferring.com.br/
Company description
In 1950 in Malmö, Sweden, Dr. Frederik Paulsen founded Laboratoriet Nordiska hormone, which in 1954 changed its name to Ferring.
A world leader in peptide hormones, Ferring was a pioneer in developing and selling pharmaceutical products based on natural hormones, the pituitary-produced peptide. Dr. Paulsen was convinced that these new compounds could be used to supplement deficiencies and abnormalities, making an invaluable role in the treatment of various diseases.
Five decades later, Dr. Paulsen’s predictions have proven inaccurate. Today, the peptides are widely used in various treatments of Ferring.
Over the past years Ferring has expanded its activities beyond its European base and now have subsidiaries operating in over 40 countries, including Brazil, which is the company’s fastest-growing subsidiary. Its annual turnover is 700 million and has over 3,000 employees. Over the next three to five years, the group aims to triple sales in Brazil.
Products and services
Propess, BioGaia, DDAVP, Choragon, Bravelle, FemLab, Menogon
Related
Brazil / Pharma Market Outperforming LatAm, Vaccine Developments, Bolsonaro’s Political Standing
The Brazilian pharma market outperformed the Latin American average in Q1 of 2020 with a growth of 8.2 percent in…
Brazil / Top 5 Pharma Companies
Six of the top ten companies in the Brazilian pharma market are domestic.* Read on for an introduction to some of…
Brazil / Six Trends in the OTC Market Post-COVID-19
Panorama Faramceutico’s editorial team look at how the ongoing COVID-19 pandemic stands to affect Brazil’s over…
Clinical Trials / Chinese Sinovac Testing COVID-19 Vaccine in Brazil
In the race to develop the world’s first COVID-19 vaccine, Brazil – now one of the world’s…
LatAm / COVID-19 and the Brazilian Pharma Supply Chain
The editorial team at Panorama Farmaceutico explain how the COVID-19 pandemic and global trade flow stoppages are…
LatAm / What Can Brazil’s Pharma Industry Learn from India?
The editorial team at Panorama Farmaceutico explain why coordinated action is needed within Brazilian pharma to…
News Roundup / Brazilian Pharma April 2020
Below we highlight recent news in Brazilian pharma, including the impact of coronavirus as well as legal and…
Research Partnerships / Novartis Teams Up to Tackle Neglected Diseases in Brazil
Swiss pharma giant Novartis is teaming up with the Oswaldo Cruz Foundation (Fiocruz) in Brazil to conduct research…
Talent / Pharma Leadership Strategies for Brazil
Three seasoned pharma executives with a wealth of experience working in Brazil offer their insights on leadership…
Why Pharma Needs Transformational Leaders
Rodrigo Araujo of global organizational consulting firm Korn Ferry outlines what he sees as the leadership profile…
The Big Chill: Temperature-Sensitive Pharma Logistics in Brazil
When combining the sheer size of Brazil – the fifth largest country in the world – with its tropical…
